CAV1 and breast cancer: As shown in Figure 10A, ADQ synergistically interacted with paclitaxel to suppress MCF-7 cell proliferation, whereas CAV1 overexpression obviously abrogated the synergistic effects of ADQ with paclitaxel in suppressing breast cancer growth (p ≤ 0.01).